-
Christen Countryteam
- logged in as: countryteam@sycamore.com
- Change Password
- Logout
- Manage Therapeutic Areas
- Manage Drugs/Treatments
- Manage Users
- 2
Name | Project Type | Feasibility Strategist | Early Indication | Protocol | Site | Last Update | |
---|---|---|---|---|---|---|---|
Alimta Mesothelioma (27283) | Early Indication Feasibility | Anita Barberri | Ongoing | Planned | Planned | ||
Alimta multi cohort trial (72623) | Early Indication Feasibility | Roger Flint | Closed | Ongoing | Planned | 1 | |
Fanpibumab IBS (53535) | Site Feasibility | Christian Willows | Closed | Ongoing | Planned | 2 | |
Vitrupubin/Avastin CHF SOC (11223) | Site Feasibility | Madison Filipo, Anita Barberri |
Ongoing | Planned | Planned | 3 | |
HRX232 inhibitor for 2nd line (43312) | Site Feasibility | Sunita Kahn | Closed | Closed | Ongoing | 1 | |
Xenovascumab/Monifibercept DME AMD (53229, 34210) | Protocol Feasibility | Xinxia Peng | Closed | Closed | Planned | Adrian Frody | |
Rocinantin ASTRAL 1 (23467) | Protocol Feasibility | Christian Willows | Closed | Closed | Closed | 1 | |
Rocinantin ASTRAL 5 (23468) | Protocol Feasibility | Adrian Frody | On Hold | On Hold | On Hold | ||
Rocinantin ASTRAL 3 (23470) | Site Feasibility | Madison Filipo | Closed | Closed | Ongoing | 2 |